GBE.F · Genus plc

-

Please sign in to comment on GBE.F

1 Comment

Admin

4 years, 6 months ago

Genus plc is currently in a long term uptrend where the price is trading 11.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.

Genus plc's total revenue sank by 0.0% to $135M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.

Finally, its free cash flow grew by 120.0% to $14M since the same quarter in the previous year.

Based on the above factors, Genus plc gets an overall score of 3/5.

Exchange	F
CurrencyCode	EUR
ISIN	GB0002074580
Sector	Healthcare
Industry	Biotechnology

Market Cap	2B
Beta	0.62
Dividend Yield	1.0%
PE Ratio	91.52
Target Price	None

ABOUT

Genus plc

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GBE.F · Genus plc

-

Genus plc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Genus plc using a moving average strategy